Document is current

Any future updates will be listed below

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease

Crossref DOI link: https://doi.org/10.1186/s13075-016-1203-y

Published Online: 2016-12-30

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark